Prudential plc’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.68M | Buy |
30,480
+24,114
| +379% | +$1.33M | 0.01% | 431 |
|
|
2025
Q1 | $450K | Buy |
+6,366
| New | +$450K | ﹤0.01% | 611 |
|
|
2024
Q1 | – | Sell |
-7,053
| Closed | -$680K | – | 761 |
|
|
2023
Q4 | $680K | Sell |
7,053
-19
| -0.3% | -$1.83K | 0.01% | 691 |
|
|
2023
Q3 | $626K | Sell |
7,072
-1,658
| -19% | -$147K | 0.01% | 679 |
|
|
2023
Q2 | $757K | Sell |
8,730
-94
| -1% | -$8.15K | 0.01% | 671 |
|
|
2023
Q1 | $858K | Buy |
8,824
+1,395
| +19% | +$136K | 0.01% | 607 |
|
|
2022
Q4 | $769K | Buy |
7,429
+3,599
| +94% | +$372K | 0.01% | 642 |
|
|
2022
Q3 | $325K | Sell |
3,830
-12,293
| -76% | -$1.04M | 0.01% | 687 |
|
|
2022
Q2 | $1.34M | Sell |
16,123
-6,708
| -29% | -$556K | 0.02% | 356 |
|
|
2022
Q1 | $1.76M | Buy |
22,831
+2,952
| +15% | +$228K | 0.03% | 329 |
|
|
2021
Q4 | $1.76M | Sell |
19,879
-691
| -3% | -$61K | 0.02% | 290 |
|
|
2021
Q3 | $1.59M | Buy |
+20,570
| New | +$1.59M | 0.02% | 263 |
|